To overcome this limitation, considering that TB-specific CD8+ T lymphocytes are more efficiently stimulated by the recombinant protein antigens used in TBF, TBF would be a useful alternative to current IGRAs such as QFT-Plus, especially for immunocompromised patients who undergo IGRA tests to diagnose MTB infection [18]. The gene discussed is CD8A; the disease is tuberculosis.